A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

Respiratory Research

Volumn 16, Issue 1, 2015, Pages

  Vogelberg, Christian ^a   Moroni Zentgraf, Petra ^b   Leonaviciute Klimantaviciene, Migle ^c   Sigmund, Ralf ^b   Hamelmann, Eckard ^d   Engel, Michael ^b   Szefler, Stanley ^e  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c VILNIUS UNIVERSITY   (Lithuania)

^d EVANGELISCHES KRANKENHAUS   (Germany)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Asthma control; Children; Lung function; Once daily; Paediatric; Respimat ; Tiotropium

Indexed keywords

BUDESONIDE; CORTICOSTEROID; LEUKOTRIENE; PLACEBO; SALBUTAMOL; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

AREA UNDER THE CURVE; ARTICLE; ASTHMA; BRONCHITIS; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CONTUSION; COUGHING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLUENZA; LUNG FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MUSCULOSKELETAL INJURY; PEAK EXPIRATORY FLOW; PHARMACODYNAMICS; PHARYNGITIS; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; RHINOPHARYNGITIS; SCHOOL CHILD; SOFT MIST INHALER; STOMATITIS; THORAX PAIN; URINARY TRACT INFECTION; VIRAL UPPER RESPIRATORY TRACT INFECTION; AGE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; NEBULIZER; PATHOPHYSIOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGE FACTORS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE ANTAGONISTS; LUNG; MALE; NEBULIZERS AND VAPORIZERS; TIME FACTORS; TIOTROPIUM BROMIDE; TREATMENT OUTCOME;

EID: 84927717677     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-015-0175-9     Document Type: Article

References (29)

1. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy 2012, 67:976-997. 10.1111/j.1398-9995.2012.02865.x, 22702533.
2. 2011 National Health Interview Survey (NHIS) Data. 2011 Lifetime Asthma, Current Asthma, Asthma Attacks among those with Current Asthma [http://www.cdc.gov/asthma/nhis/2011/data.htm]..
3. Lung health in Europe: facts and figures [http://www.europeanlung.org/assets/files/en/publications/lung_health_in_europe_facts_and_figures_web_vfour.pdf]..
4. Liu AH, Gilsenan AW, Stanford RH, Lincourt W, Ziemiecki R, Ortega H. Status of asthma control in pediatric primary care: results from the pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS). J Pediatr 2010, 157:276-81. 10.1016/j.jpeds.2010.02.017, 20472251.
5. Guilbert TW, Garris C, Jhingran P, Bonafede M, Tomaszewski KJ, Bonus T, et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma 2011, 48:126-32. 10.3109/02770903.2010.535879, 21128880.
6. Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2009, 124:895-902.e4. 10.1016/j.jaci.2009.07.035, 19811812.
7. Custovic A, Johnston SL, Pavord I, Gaga M, Fabbri L, Bel EH, et al. EAACI position statement on asthma exacerbations and severe asthma. Allergy 2013, 68:1520-31. 10.1111/all.12275, 24410781.
8. Asthma's Impact on the Nation: Data from the CDC National Asthma Control Program [http://www.cdc.gov/asthma/impacts_nation/asthmafactsheet.pdf]..
9. Global strategy for asthma management and prevention. Revised 2014 [http://www.ginasthma.org/local/uploads/files/GINA_Report_2014_Jun11.pdf]..
10. Chang C. Asthma in children and adolescents: a comprehensive approach to diagnosis and management. Clin Rev Allergy Immunol 2012, 43:98-137. 10.1007/s12016-011-8261-3, 22187333.
11. Desai M, Oppenheimer JJ. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep 2011, 11:454-64. 10.1007/s11882-011-0227-2, 21968618.
12. Wildhaber J, Carroll WD, Brand PL. Global impact of asthma on children and adolescents' daily lives: the room to breathe survey. Pediatr Pulmonol 2012, 47:346-57. 10.1002/ppul.21557, 22028276.
13. Hennessy-Harstad E. Asthma and adolescents: review of strategies to improve control. J Sch Nurs 2013, 29:39-51. 10.1177/1059840512454546, 22815347.
14. Rhee H, Belyea MJ, Halterman JS. Adolescents' perception of asthma symptoms and health care utilization. J Pediatr Health Care 2011, 25:105-13. 10.1016/j.pedhc.2009.10.003, 21320682.
15. Disse B, Speck GA, Rominger KL, Witek TJ, Hammer R. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 1999, 64:457-64. 10.1016/S0024-3205(98)00588-8, 10069510.
16. Sposato B, Calabrese A, Barzan R, Franco C. Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma. J Asthma 2008, 45:397-401. 10.1080/02770900802069125, 18569233.
17. Bateman ED, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri LM. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011, 128:315-22. 10.1016/j.jaci.2011.06.004, 21807250.
18. Kerstjens HAM, Disse B, Schröder-Babo W, Bantje TA, Gahlemann M, Sigmund R, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011, 128:308-14. 10.1016/j.jaci.2011.04.039, 21636120.
19. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010, 363:1715-26. 10.1056/NEJMoa1008770, 20979471.
20. Kerstjens HAM, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012, 367:1198-207. 10.1056/NEJMoa1208606, 22938706.
21. Beeh KM, Moroni-Zentgraf P, Ablinger O, Hollaenderova Z, Unseld A, Engel M, et al. Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma. Respir Res 2014, 15:61. 10.1186/1465-9921-15-61, 24890738.
22. Vogelberg C, Engel M, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M, Sigmund R, Downie J, et al. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study. Respir Med 2014, 108:1268-76. 10.1016/j.rmed.2014.06.011, 25081651.
23. Littner MR, Ilowite JS, Tashkin DP, Friedman M, Serby CW, Menjoge SS, et al. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1136-42. 10.1164/ajrccm.161.4.9903044, 10764302.
24. van Noord JA, Smeets JJ, Custers FLJ, Korducki L, Cornelissen PJG. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. Eur Respir J 2002, 19:639-44. 10.1183/09031936.02.00238002, 11998992.
25. Callahan KA, Panter TM, Hall TM, Slemmons M. Peak flow monitoring in pediatric asthma management: a clinical practice column submission. J Pediatr Nurs 2010, 25:12-7. 10.1016/j.pedn.2008.06.009, 20117670.
26. Kerstjens HAM, Bleecker E, Meltzer E, Casale T, Pizzichini E, Schmidt O, et al. Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: lung function and safety [abstract 4629]. Eur Respir J 2013, 42((Suppl 57)):980s-1.
27. Paggiaro P, Engel M, Tudoriæ N, Forstner B, Radeczky E, Zubek V, et al. Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: design and planned analyses [abstract P4133]. Eur Respir J. 2013;42(Suppl 57)..
28. Beeh KM, Ablinger O, Moroni-Zentgraf P, Engel M, Hollaenderova Z, Pivovarova A, et al. Tiotropium in asthma: a dose-finding study in adult patients with moderate persistent asthma [abstract A1283]. Am J Respir Crit Care Med. 2013;187..
29. Dalby R, Spallek M, Voshaar T. A review of the development of Respimat® Soft Mist™ Inhaler. Int J Pharm 2004, 283:1-9. 10.1016/j.ijpharm.2004.06.018, 15363496.